Lantern Pharma (LTRN) Advances Oncology AI and Gains Orphan Drug Recognition

Lantern Pharma, Inc. (NASDAQ:LTRN) is one of the best AI penny stocks to buy right now. On January 20, the FDA granted Lantern Pharma, Inc.’s (NASDAQ:LTRN) LP-284 an Orphan Drug Designation (ODD). LP-284 is an investigational small-molecule therapy for treating soft tissue sarcomas. Lantern Pharma (LTRN) Advances Oncology AI and Gains Orphan Drug Recognition According to Lantern Pharma, the ODD designation applies in the United States under the FDA’s orphan drug program. The program supports the developm ...